TGFB1 and pancreatic ductal adenocarcinoma: However, only limited or no activity was demonstrated in pancreatic ductal adenocarcinoma,11–13 due to the presence of multiple immunosuppressive entities within the tumor microenvironment (TME), such as transforming growth factor-beta (TGF-β).